Mittermayer B. Santiago

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis

Richard Furie, Brad H. Rovin, Frédéric Houssiau et al. · New England Journal of Medicine · 2020 · 903 citations · Full text

Type I interferon inhibitor anifrolumab in active systemic lupus erythematosus (TULIP-1): a randomised, controlled, phase 3 trial

Richard Furie, Eric F. Morand, Ian N Bruce et al. · The Lancet Rheumatology · 2019 · 442 citations · Full text

Inflammation, Autoimmune Disease, Systemic Lupus Erythematosus Treatment +10

Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis

Richard Furie, Brad H. Rovin, Jay Garg et al. · New England Journal of Medicine · 2025 · 122 citations · Full text

A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis

Mittermayer B. Santiago, Murray Baron, Kiyomitsu Miyachi et al. · Clinical Rheumatology · 2007 · 100 citations

Inflammation, Rheumatology, Rheumatoid Disorder +14

Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA.

Mittermayer B. Santiago, Murray Baron, Marie Hudson et al. · PubMed · 2007 · 69 citations